PeriPharm Inc.
Canadian consultancy specializing in pharmacoeconomics and health evaluative research, supporting market access for innovative therapies.
Last updated September 27, 2026
AI crawler reads
2requests
1companies- Anthropic2
- Profile
- 2
- Controversies
- 0
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
PeriPharm Inc. is a Canadian company founded in 2003 and based in Montreal, Quebec. It specializes in pharmacoeconomics and health evaluative research, with a mission to provide high-quality, diversified services that ensure optimal market access for its clients. The firm works closely with clients to meet the needs of the pharmaceutical and health technology industry, leveraging deep knowledge of the Canadian healthcare system and payer requirements. PeriPharm's core services include payer submissions (for INESSS, CDR, and private payers), economic evaluations in health (economic model development, budget impact analyses, cost-of-disease studies, and negotiation tools), real-world evidence research (patient-reported outcomes, administrative database analyses, and key opinion leader interviews), evidence synthesis (systematic literature reviews, network meta-analyses, and indirect comparisons), strategic consulting (licensing opportunity assessment, market access strategic plans, and critical review of payer submissions), and health economics training (introductory pharmacoeconomics and customized training). The company distinguishes itself through its rigorous academic approach, recognized expertise in pharmacoeconomics and evaluative research spanning over 20 years, and a commitment to flexibility and client service. PeriPharm has contributed to the success of numerous market access initiatives in Canada. It operates as a private company and is not publicly listed.
History
PeriPharm Inc. was founded in 2003 as a Canadian company specializing in pharmacoeconomics and health evaluative research. Based in Montreal, Quebec, the firm has built its reputation on providing high-quality services to support market access for innovative health technologies. Over more than two decades, PeriPharm has developed deep expertise in the Canadian healthcare system and payer requirements, contributing to numerous successful market access initiatives. The company's rigorous academic approach and flexible service offerings have positioned it as a leader in its field. As of its official website, PeriPharm continues to operate as a private consultancy serving the pharmaceutical and health technology industries.
- 2003
PeriPharm Inc. founded in Canada.
Products and positioning
Academic rigor and deep knowledge of the Canadian healthcare system to facilitate market access for innovative therapies.
Payer submissions
Preparation of reimbursement requests for INESSS, CDR and private payers.
Economic evaluations in health
Development and adaptation of economic models, budget impact analyses, cost-of-disease studies, and negotiation tools.
Real-world evidence research
Patient-reported outcomes, administrative database analyses, and key opinion leader interviews.
Evidence synthesis
Systematic literature reviews, network meta-analyses, and indirect comparisons.
Strategic consulting
Licensing opportunity assessment, market access strategic plans, and critical review of payer submissions.
Health economics training
Introductory pharmacoeconomics and customized training.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/peripharm-inc-canada · Editorial policy · How profiles are compiled